232 related articles for article (PubMed ID: 20816090)
1. Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action.
Wunderlich FT; Ströhle P; Könner AC; Gruber S; Tovar S; Brönneke HS; Juntti-Berggren L; Li LS; van Rooijen N; Libert C; Berggren PO; Brüning JC
Cell Metab; 2010 Sep; 12(3):237-49. PubMed ID: 20816090
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 is a protective factor against diet-induced insulin resistance in liver.
Cintra DE; Pauli JR; Araújo EP; Moraes JC; de Souza CT; Milanski M; Morari J; Gambero A; Saad MJ; Velloso LA
J Hepatol; 2008 Apr; 48(4):628-37. PubMed ID: 18267346
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
4. The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice.
Pinto Lde F; Compri CM; Fornari JV; Bartchewsky W; Cintra DE; Trevisan M; Carvalho Pde O; Ribeiro ML; Velloso LA; Saad MJ; Pedrazzoli J; Gambero A
Liver Int; 2010 Apr; 30(4):603-10. PubMed ID: 20088867
[TBL] [Abstract][Full Text] [Related]
5. Role of hepatic STAT3 in brain-insulin action on hepatic glucose production.
Inoue H; Ogawa W; Asakawa A; Okamoto Y; Nishizawa A; Matsumoto M; Teshigawara K; Matsuki Y; Watanabe E; Hiramatsu R; Notohara K; Katayose K; Okamura H; Kahn CR; Noda T; Takeda K; Akira S; Inui A; Kasuga M
Cell Metab; 2006 Apr; 3(4):267-75. PubMed ID: 16581004
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance.
Netea MG; Joosten LA; Lewis E; Jensen DR; Voshol PJ; Kullberg BJ; Tack CJ; van Krieken H; Kim SH; Stalenhoef AF; van de Loo FA; Verschueren I; Pulawa L; Akira S; Eckel RH; Dinarello CA; van den Berg W; van der Meer JW
Nat Med; 2006 Jun; 12(6):650-6. PubMed ID: 16732281
[TBL] [Abstract][Full Text] [Related]
7. Kupffer cell activation is a causal factor for hepatic insulin resistance.
Lanthier N; Molendi-Coste O; Horsmans Y; van Rooijen N; Cani PD; Leclercq IA
Am J Physiol Gastrointest Liver Physiol; 2010 Jan; 298(1):G107-16. PubMed ID: 19875703
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 and insulin resistance.
Kim JH; Bachmann RA; Chen J
Vitam Horm; 2009; 80():613-33. PubMed ID: 19251052
[TBL] [Abstract][Full Text] [Related]
9. Glycine regulates the production of pro-inflammatory cytokines in lean and monosodium glutamate-obese mice.
Alarcon-Aguilar FJ; Almanza-Perez J; Blancas G; Angeles S; Garcia-Macedo R; Roman R; Cruz M
Eur J Pharmacol; 2008 Dec; 599(1-3):152-8. PubMed ID: 18930730
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 1beta and interleukin 6, but not tumor necrosis factor alpha, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes.
Kanemaki T; Kitade H; Kaibori M; Sakitani K; Hiramatsu Y; Kamiyama Y; Ito S; Okumura T
Hepatology; 1998 May; 27(5):1296-303. PubMed ID: 9581683
[TBL] [Abstract][Full Text] [Related]
11. Diet-genotype interactions in the early development of obesity and insulin resistance in mice with a genetic deficiency in tumor necrosis factor-alpha.
Bouter B; Geary N; Langhans W; Asarian L
Metabolism; 2010 Jul; 59(7):1065-73. PubMed ID: 20045154
[TBL] [Abstract][Full Text] [Related]
12. Alterations in calcium signaling and cellular responses in septic injury.
Sayeed MM
New Horiz; 1996 Feb; 4(1):72-86. PubMed ID: 8689277
[TBL] [Abstract][Full Text] [Related]
13. Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice.
Choi YH; Park S; Hockman S; Zmuda-Trzebiatowska E; Svennelid F; Haluzik M; Gavrilova O; Ahmad F; Pepin L; Napolitano M; Taira M; Sundler F; Stenson Holst L; Degerman E; Manganiello VC
J Clin Invest; 2006 Dec; 116(12):3240-51. PubMed ID: 17143332
[TBL] [Abstract][Full Text] [Related]
14. Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines.
Kang L; Sebastian BM; Pritchard MT; Pratt BT; Previs SF; Nagy LE
Alcohol Clin Exp Res; 2007 Sep; 31(9):1581-8. PubMed ID: 17624994
[TBL] [Abstract][Full Text] [Related]
15. Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production.
Könner AC; Janoschek R; Plum L; Jordan SD; Rother E; Ma X; Xu C; Enriori P; Hampel B; Barsh GS; Kahn CR; Cowley MA; Ashcroft FM; Brüning JC
Cell Metab; 2007 Jun; 5(6):438-49. PubMed ID: 17550779
[TBL] [Abstract][Full Text] [Related]
16. Role reversal: brain insulin and liver STAT3.
Myers MG
Cell Metab; 2006 Apr; 3(4):231-2. PubMed ID: 16580998
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling.
Qin B; Anderson RA; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1120-9. PubMed ID: 18372392
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 depletion selectively improves hepatic insulin action in obesity.
Klover PJ; Clementi AH; Mooney RA
Endocrinology; 2005 Aug; 146(8):3417-27. PubMed ID: 15845623
[TBL] [Abstract][Full Text] [Related]
19. Temporal and tissue-specific requirements for T-lymphocyte IL-6 signalling in obesity-associated inflammation and insulin resistance.
Xu E; Pereira MMA; Karakasilioti I; Theurich S; Al-Maarri M; Rappl G; Waisman A; Wunderlich FT; Brüning JC
Nat Commun; 2017 May; 8():14803. PubMed ID: 28466852
[TBL] [Abstract][Full Text] [Related]
20. Selective depletion of hepatic Kupffer cells significantly alleviated hepatosteatosis and intrahepatic inflammation induced by high fat diet.
Chen L; Ye H; Zhao X; Miao Q; Li Y; Hu R
Hepatogastroenterology; 2012 Jun; 59(116):1208-12. PubMed ID: 22328286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
